Clinical Trial

Restrictions on availability Products 15

• Casirivimab 120mg/ml solution for infusion 11.1ml vials (Roche Products Ltd)
• Casirivimab 120mg/ml solution for infusion 11.1ml vials and Imdevimab 120mg/ml solution for infusion...
• Casirivimab 120mg/ml solution for infusion 2.5ml vials (Roche Products Ltd)
• Casirivimab 120mg/ml solution for infusion 2.5ml vials and Imdevimab 120mg/ml solution for infusion ...
• COVID-19 Vaccine AZD2816 AstraZeneca (ChAdOx1 nCOV-19) 3.5x10,000,000,000 viral particles/0.5ml dose...
• COVID-19 Vaccine Medicago (CoVLP) 3.75micrograms/0.5ml dose emulsion for injection multidose vials (...
• COVID-19 Vaccine Moderna (mRNA-1273.214) 50micrograms/0.5ml dose dispersion for injection vials (Mod...
• COVID-19 Vaccine Moderna (mRNA-1273.529) 50micrograms/0.25ml dose solution for injection multidose v...
• COVID-19 Vaccine Sanofi (CoV2 preS dTM bivalent D614+B.1.351 [recombinant adjuvanted]) 2.5micrograms...
• COVID-19 Vaccine Sanofi (CoV2 preS dTM monovalent B.1.351 [recombinant adjuvanted]) 5micrograms/0.5m...
• COVID-19 Vaccine Sanofi (CoV2 preS dTM monovalent D614 [recombinant]) 5micrograms/0.5ml dose suspens...
• COVID-19 Vaccine Valneva (inactivated adjuvanted whole virus) 40antigen units/0.5ml dose suspension ...
• Imdevimab 120mg/ml solution for infusion 11.1ml vials (Roche Products Ltd)
• Imdevimab 120mg/ml solution for infusion 2.5ml vials (Roche Products Ltd)
• Sotrovimab 500mg/8ml solution for infusion vials (GlaxoSmithKline UK Ltd)